quinoxalines has been researched along with Lymphoma, Large B-Cell, Diffuse in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, JX; Ju, SG; Li, J; Ling, HY; Sun, Y; Wang, PJ; Yang, Z | 1 |
| Ebata, K; Hirata, K; Katagiri, M; Nakajima, S; Ozasa, M; Sakamoto, N; Sasaki, T; Suda, G; Takahash, S; Takano, M; Tsukamoto, S; Umemura, M | 1 |
2 other study(ies) available for quinoxalines and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.
Topics: Cell Line, Tumor; Cytokine Receptor gp130; Exosomes; Humans; Hydrazines; Immunophenotyping; Lymphoma, Large B-Cell, Diffuse; Models, Biological; Phenotype; Quinoxalines; Signal Transduction; STAT3 Transcription Factor; Tumor Microenvironment; Tumor-Associated Macrophages | 2022 |
Successful treatment by on-demand glecaprevir and pibrentasvir for hepatitis C flare during R-CHOP in patients with diffuse large B-cell lymphoma: a case report.
Topics: Aminoisobutyric Acids; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Benzimidazoles; Cyclophosphamide; Cyclopropanes; Doxorubicin; Genotype; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Leucine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Proline; Pyrrolidines; Quinoxalines; Rituximab; RNA, Viral; Sulfonamides; Sustained Virologic Response; Vincristine; Viral Load | 2021 |